Adipocytes impact on gastric cancer progression: Prognostic insights and molecular features

Figure 3 Construction and validation of the prognostic nomogram. A: A prognostic nomogram for predicting the overall survival (OS) of gastric cancer patients at 1 year, 3 years, and 5 years; B: Time-dependent receiver operating characteristic curve analysis of the prognostic nomogram in the training set at 1 year, 3 years, and 5 years; C: Time-dependent receiver operating characteristic curve analysis of the prognostic nomogram in the validation set at 1 year, 3 years, and 5 years; D: Area under the curve (AUC) comparison of the nomogram with all independent factors in the training set at 1 year; E: AUC comparison of the nomogram with all independent factors in the training set at 3 years; F: AUC comparison of the nomogram with all independent factors in the training set at 5 years; G: AUC comparison of the nomogram with all independent factors in the validation set at 1 year; H: AUC comparison of the nomogram with all independent factors in the validation set at 3 years; I: AUC comparison of the nomogram with all independent factors in the validation set at 5 years; J: Calibration curves of the nomogram for 1 year in the training set; K: Calibration curves of the nomogram for 3 years in the training set; L: Calibration curves of the nomogram for 5 years in the training set; M: Calibration curves of the nomogram for 1 year in the validation set; N: Calibration curves of the nomogram for 3 years in the validation set; O: Calibration curves of the nomogram for 5 years in the validation set. ^aP < 0.01, ^bP < 0.0001. FP: False positive; TP: True positive.